Post‐hematopoietic stem cell transplantation relapse: Role of checkpoint inhibitors

Post‐hematopoietic stem cell transplantation relapse: Role of checkpoint inhibitors

Abstract Background and Aims Despite the revolutionary effects of hematopoietic stem cell transplantation (HSCT) in treating hematological malignancies, post‐HSCT relapse is considered a critical concern of clinicians. Residual malignant cells employ many mechanisms to evade immune surveillance and...

Full description

Bibliographic Details
Main Authors: Elham Roshandel, Farzaneh Tavakoli, Sayeh Parkhideh, Sedigheh Sadat Akhlaghi, Maria Tavakoli Ardakani, Masoud Soleimani
Format: Article
Language:English
Published: Wiley 2022-03-01
Series:Health Science Reports
Subjects:
checkpoint blocker
hematopoietic stem cell transplantation
immune checkpoint
relapse
Online Access:https://doi.org/10.1002/hsr2.536

Internet

https://doi.org/10.1002/hsr2.536

Similar Items